Those with fibrosis regression had lower mean baseline fasting insulin levels (mean [SD], 20 [11] vs 33 [41] μU/mL; P = .02) and a greater decrease in AST and ALT levels from the time of the first to last biopsy (eTable 5 in the Supplement). Here, INS is linked to fibrosis.